Gastroenterology
Volume 133, Issue 2 , Pages 702-705 , August 2007

In Search of Mechanisms of Change in Treatment Outcome Research: Mediators and Moderators of Psychological and Pharmacological Treatments for Irritable Bowel Syndrome

  • Jennifer S. Labus

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Jennifer Labus, PhD, Center for Neurovisceral Sciences and Women’s Health, Neuroimaging Imaging Core, Peter V. Ueberroth Building, Room 2338C2, 10945 LeConte Avenue, Los Angeles, California 90095. fax: (310) 825-1919.

  • Image Result

    Targets within the brain–gut axis for the treatment of FGIs. Shown are general target areas for various therapeutic approaches to IBS symptoms. Whereas neurologically directed pharmacologic therapies

    Targets within the brain–gut axis for the treatment of FGIs. Shown are general target areas for various therapeutic approaches to IBS symptoms. Whereas neurologically directed pharmacologic therapies aim for targets within the spinal cord, brain stem, and limbic and paralimbic regions, psychological therapies are likely to affect thoughts, belief systems, and memories processed in the prefrontal cortex. Through this effect, they may strengthen the cortico–limbic–pontine pain inhibition system and counteract central pain amplification. Modified from Mayer et al.2

 Supported in part by K08 DK071626, R24 AT002681, P50 DK064539

PII: S0016-5085(07)01226-7

doi: 10.1053/j.gastro.2007.06.052

Gastroenterology
Volume 133, Issue 2 , Pages 702-705 , August 2007